Human microbiome drug targets : modern approaches in disease management /

Human Microbiome Drug Targets: Modern Approaches in Disease Management presents fundamental information on the human microbiome, looking into the relationship between the microbiome and how it changes with specific diseases. Delving into the multifaceted roles of the microbiome in health and disease...

Mô tả đầy đủ

Đã lưu trong:
Chi tiết về thư mục
Tác giả khác: Dable-Tupas, Genevieve (Biên tập viên), Karunakaran, Rohini (Biên tập viên), Lim, Peter Paul C. (Biên tập viên), Otero, Maria Catherine B. (Biên tập viên)
Định dạng: Điện tử eBook
Ngôn ngữ:Tiếng Anh
Được phát hành: Amsterdam, Netherlands ; London, United Kingdom ; Cambridge, MA, United States : Elsevier, [2025]
Loạt:Drug discovery update
Những chủ đề:
Truy cập trực tuyến:ScienceDirect
Các nhãn: Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!

MARC

LEADER 00000cam a2200000 i 4500
001 on1465429480
003 OCoLC
005 20260915095219.0
006 m o d
007 cr cnu---unuuu
007 tu
008 241104t20252025ne a ob 001 0 eng d
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d OCLCO  |d OCLCL  |d SFB  |d TFW  |d OCLCO  |d OCLCF  |d OCLCO  |d OCLCQ 
020 |a 9780443154362  |q (electronic book) 
020 |a 0443154368  |q (electronic book) 
020 |z 9780443154355 
035 |a (OCoLC)1465429480 
050 4 |a QR46 
082 0 4 |a 612.001/579  |2 23/eng/20241104  |1 https://id.oclc.org/worldcat/ddc/E3YXrDwQ4rG3txgdXgH4W9WTHt 
245 0 0 |a Human microbiome drug targets :  |b modern approaches in disease management /  |c edited by Genevieve Dable-Tupas, Rohini Karunakaran, Peter Paul C. Lim, Maris Catherine B. Otero. 
264 1 |a Amsterdam, Netherlands ;  |a London, United Kingdom ;  |a Cambridge, MA, United States :  |b Elsevier,  |c [2025] 
264 4 |c ©2025 
300 |a 1 online resource :  |b color illustrations. 
334 |a single unit  |b mono  |0 http://id.loc.gov/vocabulary/issuance/mono 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
340 |p illustration  |0 http://rdaregistry.info/termList/IllusContent/1014  |2 rdaill 
340 |g polychrome  |0 http://rdaregistry.info/termList/RDAColourContent/1003  |2 rdacc 
347 |a text file  |2 rdaft  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
353 |a bibliography  |b bibliography  |0 http://id.loc.gov/vocabulary/msupplcont/bibliography 
353 |a index  |b index  |0 http://id.loc.gov/vocabulary/msupplcont/index 
490 0 |a Drug discovery update 
504 |a Includes bibliographical references and index. 
520 |a Human Microbiome Drug Targets: Modern Approaches in Disease Management presents fundamental information on the human microbiome, looking into the relationship between the microbiome and how it changes with specific diseases. Delving into the multifaceted roles of the microbiome in health and disease, the book's chapters discuss the role of the human microbiome in the pathophysiologic understanding of relevant diseases or disorders and their management. As changes in the human microbiome can provide clues to the probable cause and effect of diseases or disorders, as well as the impacts of therapy or intervention, this book is a welcomed addition to the existing research. Explaining how a better understanding of the microbiome and its impact on health and disease can pave the way for future discoveries leading to better health outcomes, this book will be of interest to drug developers, medicinal chemists, microbiologists, infectious disease specialists, biochemists, and students. 
588 0 |a Online resource; title from PDF title page (EBSCOhost platform, viewed January 21, 2026). 
505 8 |a Title of Book -- Cover image -- Title page -- Table of Contents -- Copyright -- Dedication -- Contributors -- Author description -- Preface -- Section I. Foundational information -- Chapter 1. The human microbiome: An overview -- 1 Introduction -- 1.1 Roles and functions of the human microbiome -- 1.2 Skin microbiota -- 1.3 Microbial eukaryome -- 2 Gut dysbiosis and disease development -- 2.1 Dengue and gut dysbiosis -- 2.2 Mental health and gut dysbiosis -- 2.3 Gut dysbiosis and malnutrition -- 3 Tools used in microbiome studies -- 4 Challenges and future directions -- 5 Conclusion -- AI disclosure -- Chapter 2. The gut microbiome -- 1 Introduction -- 1.1 Constitution of the normal healthy gut flora -- 2 Infancy -- 3 Gut microbiota in accordance with the anatomical location in the GI tract -- 3.1 Oral cavity -- 3.2 Pharynx  |7 Generated by AI 
650 0 |a Human beings  |x Microbiology. 
650 0 |a Drug targeting. 
650 0 |a Drug development. 
650 0 |a Pharmaceutical microbiology. 
650 6 |a Médicaments  |x Ciblage.  |0 (CaQQLa)201-0196695 
650 6 |a Médicaments  |x Développement.  |0 (CaQQLa)201-0306620 
650 6 |a Microbiologie pharmaceutique.  |0 (CaQQLa)201-0018492 
650 7 |a Drug development  |2 fast  |0 (OCoLC)fst00898670 
650 7 |a Drug targeting  |2 fast  |0 (OCoLC)fst00898709 
650 7 |a Pharmaceutical microbiology  |2 fast  |0 (OCoLC)fst01060191 
700 1 |a Dable-Tupas, Genevieve,  |e editor. 
700 1 |a Karunakaran, Rohini,  |e editor. 
700 1 |a Lim, Peter Paul C.,  |e editor. 
700 1 |a Otero, Maria Catherine B.,  |e editor. 
776 0 8 |i Print version:  |t Human microbiome drug targets.  |d Amsterdam, Netherlands ; London, United Kingdom ; Cambridge, MA, United States : Elsevier, [2025]  |z 9780443154355 
856 4 0 |3 ScienceDirect  |u https://www.sciencedirect.com/science/book/9780443154355